← SynDRA
Azemiglitazone
SynDRA canonical compound SYN0043965 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | MPC1 | MPC2 |
|---|
| Mechanism of action | mitochondrial pyruvate carrier modulator |
|---|
Cross-references
Synonyms
- MSDC 0602
- RefChem:159938
- UNII-81MXZ6QOBM
- YAUMOGALQJYOJQ-UHFFFAOYSA-N
- MFCD28502493
- AZEMIGLITAZONE [INN]
- SCHEMBL623654
- Azemiglitazone (MSDC-0602)
- orb1302692
- AZEMIGLITAZONE [WHO-DD]
- SCHEMBL29376450
- GLXC-21115
- HMS6018K12
- MSDC-0602?
- EX-A5498
- IVB81987
- BDBM50466687
- AKOS027382993
- AC-38113
- AS-56058
- DB-090848
- HY-108022
- CS-0027173
- T4639
- N17076
- (RS)-azemiglitazone
- (RS)-azemiglitazon
- SCHEMBL2222130
- MSDC-0602 sodium
- Azemiglitazone sodium
- UNII-AG62AQ1T4W
- AG62AQ1T4W
- MSDC-0602 potassium
- RefChem:199690
- GLXC-21116
- EX-A5499
- H39214
- MSDC-0602K
- MSDC-0602K Potassium
Look up Azemiglitazone in the interactive SynDRA portal →